Related Experiment Video
Updated: Aug 13, 2026

Quantifying Yersinia pseudotuberculosis Type III Secretion System Activity Following Iron Starvation and Anaerobic Growth
Published on: May 31, 2024
Small-molecule inhibition of siderophore biosynthesis in Mycobacterium tuberculosis and Yersinia pestis
Julian A Ferreras1, Jae-Sang Ryu, Federico Di Lello
1Department of Microbiology and Immunology, Weill Medical College of Cornell University, 1300 York Ave., Box 62, New York, New York 10021, USA.
Abstract:
Mycobacterium tuberculosis and Yersinia pestis, the causative agents of tuberculosis and plague, respectively, are pathogens with serious ongoing impact on global public health and potential use as agents of bioterrorism. Both pathogens have iron acquisition systems based on siderophores, secreted iron-chelating compounds with extremely high Fe3+ affinity. Several lines of evidence suggest that siderophores have a critical role in bacterial iron acquisition inside the human host, where the free iron concentration is well below that required for bacterial growth and virulence. Thus, siderophore biosynthesis is an attractive target in the development of new antibiotics to treat tuberculosis and plague. In particular, such drugs, alone or as part of combination therapies, could provide a valuable new line of defense against intractable multiple-drug-resistant infections. Here, we report the design, synthesis and biological evaluation of a mechanism-based inhibitor of domain salicylation enzymes required for siderophore biosynthesis in M. tuberculosis and Y. pestis. This new antibiotic inhibits siderophore biosynthesis and growth of M. tuberculosis and Y. pestis under iron-limiting conditions.
Insights
A novel antibiotic targeting siderophore biosynthesis effectively inhibits the growth of Mycobacterium tuberculosis and Yersinia pestis. This discovery offers a new strategy against drug-resistant tuberculosis and plague.
Area of Science:
- Microbiology
- Medicinal Chemistry
- Infectious Diseases
Background:
- Mycobacterium tuberculosis (tuberculosis) and Yersinia pestis (plague) are significant global health threats and potential bioterrorism agents.
- Both pathogens rely on siderophores for iron acquisition, crucial for virulence within the iron-limited human host.
- Targeting siderophore biosynthesis presents a promising avenue for developing novel antibiotics.
Purpose of the Study:
- To design, synthesize, and evaluate a mechanism-based inhibitor of essential enzymes in siderophore biosynthesis.
- To assess the efficacy of this inhibitor against Mycobacterium tuberculosis and Yersinia pestis.
Main Methods:
- Mechanism-based inhibitor design and chemical synthesis.
- Biological evaluation of the inhibitor's effect on siderophore biosynthesis.
- Assessment of bacterial growth inhibition under iron-limiting conditions.
Main Results:
- Successful design and synthesis of a novel mechanism-based inhibitor.
- Demonstrated inhibition of siderophore biosynthesis in both M. tuberculosis and Y. pestis.
- Significant inhibition of bacterial growth for both pathogens under iron-limiting conditions.
Conclusions:
- Siderophore biosynthesis is a viable target for developing new anti-tuberculosis and anti-plague drugs.
- The developed inhibitor shows potential as a new therapeutic agent, particularly against drug-resistant strains.
- This research offers a new strategy to combat serious infectious diseases.
Related Concept Videos
Inhibitors of Bacterial Protein Synthesis
Gene Regulation in Microbial Communities: Quorum Sensing
Biological Methods for Microbial Control
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Inhibitors of Bacterial DNA Synthesis

